Cargando…

Complications Risk Assessment and Imaging Findings of Thermal Ablation Treatment in Liver Cancers: What the Radiologist Should Expect

One of the major fields of application of ablation treatment is liver tumors. With respect to HCC, ablation treatments are considered as upfront treatments in patients with early-stage disease, while in colorectal liver metastases (CLM), they can be employed as an upfront treatment or in association...

Descripción completa

Detalles Bibliográficos
Autores principales: Granata, Vincenza, Fusco, Roberta, De Muzio, Federica, Cutolo, Carmen, Setola, Sergio Venanzio, Simonetti, Igino, Dell’Aversana, Federica, Grassi, Francesca, Bruno, Federico, Belli, Andrea, Patrone, Renato, Pilone, Vincenzo, Petrillo, Antonella, Izzo, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147303/
https://www.ncbi.nlm.nih.gov/pubmed/35628893
http://dx.doi.org/10.3390/jcm11102766
_version_ 1784716774237798400
author Granata, Vincenza
Fusco, Roberta
De Muzio, Federica
Cutolo, Carmen
Setola, Sergio Venanzio
Simonetti, Igino
Dell’Aversana, Federica
Grassi, Francesca
Bruno, Federico
Belli, Andrea
Patrone, Renato
Pilone, Vincenzo
Petrillo, Antonella
Izzo, Francesco
author_facet Granata, Vincenza
Fusco, Roberta
De Muzio, Federica
Cutolo, Carmen
Setola, Sergio Venanzio
Simonetti, Igino
Dell’Aversana, Federica
Grassi, Francesca
Bruno, Federico
Belli, Andrea
Patrone, Renato
Pilone, Vincenzo
Petrillo, Antonella
Izzo, Francesco
author_sort Granata, Vincenza
collection PubMed
description One of the major fields of application of ablation treatment is liver tumors. With respect to HCC, ablation treatments are considered as upfront treatments in patients with early-stage disease, while in colorectal liver metastases (CLM), they can be employed as an upfront treatment or in association with surgical resection. The main prognostic feature of ablation is the tumor size, since the goal of the treatment is the necrosis of all viable tumor tissue with an adequate tumor-free margin. Radiofrequency ablation (RFA) and microwave ablation (MWA) are the most employed ablation techniques. Ablation therapies in HCC and liver metastases have presented a challenge to radiologists, who need to assess response to determine complication-related treatment. Complications, defined as any unexpected variation from a procedural course, and adverse events, defined as any actual or potential injury related to the treatment, could occur either during the procedure or afterwards. To date, RFA and MWA have shown no statistically significant differences in mortality rates or major or minor complications. To reduce the rate of major complications, patient selection and risk assessment are essential. To determine the right cost-benefit ratio for the ablation method to be used, it is necessary to identify patients at high risk of infections, coagulation disorders and previous abdominal surgery interventions. Based on risk assessment, during the procedure as part of surveillance, the radiologists should pay attention to several complications, such as vascular, biliary, mechanical and infectious. Multiphase CT is an imaging tool chosen in emergency settings. The radiologist should report technical success, treatment efficacy, and complications. The complications should be assessed according to well-defined classification systems, and these complications should be categorized consistently according to severity and time of occurrence.
format Online
Article
Text
id pubmed-9147303
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91473032022-05-29 Complications Risk Assessment and Imaging Findings of Thermal Ablation Treatment in Liver Cancers: What the Radiologist Should Expect Granata, Vincenza Fusco, Roberta De Muzio, Federica Cutolo, Carmen Setola, Sergio Venanzio Simonetti, Igino Dell’Aversana, Federica Grassi, Francesca Bruno, Federico Belli, Andrea Patrone, Renato Pilone, Vincenzo Petrillo, Antonella Izzo, Francesco J Clin Med Review One of the major fields of application of ablation treatment is liver tumors. With respect to HCC, ablation treatments are considered as upfront treatments in patients with early-stage disease, while in colorectal liver metastases (CLM), they can be employed as an upfront treatment or in association with surgical resection. The main prognostic feature of ablation is the tumor size, since the goal of the treatment is the necrosis of all viable tumor tissue with an adequate tumor-free margin. Radiofrequency ablation (RFA) and microwave ablation (MWA) are the most employed ablation techniques. Ablation therapies in HCC and liver metastases have presented a challenge to radiologists, who need to assess response to determine complication-related treatment. Complications, defined as any unexpected variation from a procedural course, and adverse events, defined as any actual or potential injury related to the treatment, could occur either during the procedure or afterwards. To date, RFA and MWA have shown no statistically significant differences in mortality rates or major or minor complications. To reduce the rate of major complications, patient selection and risk assessment are essential. To determine the right cost-benefit ratio for the ablation method to be used, it is necessary to identify patients at high risk of infections, coagulation disorders and previous abdominal surgery interventions. Based on risk assessment, during the procedure as part of surveillance, the radiologists should pay attention to several complications, such as vascular, biliary, mechanical and infectious. Multiphase CT is an imaging tool chosen in emergency settings. The radiologist should report technical success, treatment efficacy, and complications. The complications should be assessed according to well-defined classification systems, and these complications should be categorized consistently according to severity and time of occurrence. MDPI 2022-05-13 /pmc/articles/PMC9147303/ /pubmed/35628893 http://dx.doi.org/10.3390/jcm11102766 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Granata, Vincenza
Fusco, Roberta
De Muzio, Federica
Cutolo, Carmen
Setola, Sergio Venanzio
Simonetti, Igino
Dell’Aversana, Federica
Grassi, Francesca
Bruno, Federico
Belli, Andrea
Patrone, Renato
Pilone, Vincenzo
Petrillo, Antonella
Izzo, Francesco
Complications Risk Assessment and Imaging Findings of Thermal Ablation Treatment in Liver Cancers: What the Radiologist Should Expect
title Complications Risk Assessment and Imaging Findings of Thermal Ablation Treatment in Liver Cancers: What the Radiologist Should Expect
title_full Complications Risk Assessment and Imaging Findings of Thermal Ablation Treatment in Liver Cancers: What the Radiologist Should Expect
title_fullStr Complications Risk Assessment and Imaging Findings of Thermal Ablation Treatment in Liver Cancers: What the Radiologist Should Expect
title_full_unstemmed Complications Risk Assessment and Imaging Findings of Thermal Ablation Treatment in Liver Cancers: What the Radiologist Should Expect
title_short Complications Risk Assessment and Imaging Findings of Thermal Ablation Treatment in Liver Cancers: What the Radiologist Should Expect
title_sort complications risk assessment and imaging findings of thermal ablation treatment in liver cancers: what the radiologist should expect
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9147303/
https://www.ncbi.nlm.nih.gov/pubmed/35628893
http://dx.doi.org/10.3390/jcm11102766
work_keys_str_mv AT granatavincenza complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect
AT fuscoroberta complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect
AT demuziofederica complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect
AT cutolocarmen complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect
AT setolasergiovenanzio complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect
AT simonettiigino complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect
AT dellaversanafederica complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect
AT grassifrancesca complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect
AT brunofederico complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect
AT belliandrea complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect
AT patronerenato complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect
AT pilonevincenzo complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect
AT petrilloantonella complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect
AT izzofrancesco complicationsriskassessmentandimagingfindingsofthermalablationtreatmentinlivercancerswhattheradiologistshouldexpect